Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 11/20 | 0.72 |
| ▸ | NPC1 | O15118 | 1/20 | 0.67 |
| ▸ | RAB9A | P51151 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.63 |
| ▸ | GLP1R | P43220 | 1/20 | 0.60 |
| ▸ | GCGR | P47871 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | MDM4 | O15151 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.51 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.51 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4918238 | 0.85 | EPHX2 (0.74) | EPHX2SMN1; SMN2CYP2C9CYP2C19LMNA | |
| SCHEMBL19554663 | 0.84 | EPHX2 (0.72) | EPHX2SMN1; SMN2CYP2C9CYP2C19LMNA | |
| SCHEMBL4618267 | 0.84 | EPHX2 (1.00) | EPHX2CYP2C9CYP2C19LMNAHPGD | |
| SCHEMBL30195673 | 0.84 | EPHX2 (1.00) | EPHX2CYP2C9CYP2C19LMNAHPGD | |
| SCHEMBL5947733 | 0.84 | EPHX2 (1.00) | EPHX2SMN1; SMN2CYP2C9CYP2C19LMNA | |
| SCHEMBL3407375 | 0.82 | SMN1; SMN2 (0.60) | NPC1RAB9ASMN1; SMN2L3MBTL1LMNA | |
| SCHEMBL4618812 | 0.81 | EPHX2 (0.79) | EPHX2CYP2C9CYP2C19LMNAMEN1 | |
| SCHEMBL7703395 | 0.81 | RAB9A (1.00) | NPC1RAB9ASMN1; SMN2L3MBTL1LMNA | |
| SCHEMBL19569935 | 0.81 | EPHX2 (0.71) | EPHX2SMN1; SMN2CYP2C9CYP2C19LMNA | |
| SCHEMBL5947692 | 0.81 | EPHX2 (0.71) | EPHX2CYP2C9CYP2C19LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060276515-A1 | Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2006-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060276515-A1 | Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same | EPHX1, EPHX2, NCEH1 | EPHX2 2/4885NPC1 1489/4885RAB9A 3811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.